Barrier Protection and Recovery Effects of Gut Commensal Bacteria on Differentiated Intestinal Epithelial Cells In Vitro
- PMID: 32731411
- PMCID: PMC7468801
- DOI: 10.3390/nu12082251
Barrier Protection and Recovery Effects of Gut Commensal Bacteria on Differentiated Intestinal Epithelial Cells In Vitro
Abstract
Alterations in the gut microbiota composition play a crucial role in the pathogenesis of inflammatory bowel disease (IBD) as specific commensal bacterial species are underrepresented in the microbiota of IBD patients. In this study, we examined the therapeutic potential of three commensal bacterial species, Faecalibacterium prausnitzii (F. prausnitzii), Roseburia intestinalis (R. intestinalis) and Bacteroides faecis (B. faecis) in an in vitro model of intestinal inflammation, by using differentiated Caco-2 and HT29-MTX cells, stimulated with a pro-inflammatory cocktail consisting of interleukin-1β (IL-1β), tumor necrosis factor-α (TNFα), interferon-γ (IFNγ), and lipopolysaccharide (LPS). Results obtained in this work demonstrated that all three bacterial species are able to recover the impairment of the epithelial barrier function induced by the inflammatory stimulus, as determined by an amelioration of the transepithelial electrical resistance (TEER) and the paracellular permeability of the cell monolayer. Moreover, inflammatory stimulus increased claudin-2 expression and decreased occludin expression were improved in the cells treated with commensal bacteria. Furthermore, the commensals were able to counteract the increased release of interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) induced by the inflammatory stimulus. These findings indicated that F. prausnitzii, R. intestinalis and B. faecis improve the epithelial barrier integrity and limit inflammatory responses.
Keywords: Bacteroides faecis; Caco-2 cells; Faecalibacterium prausnitzii; HT29-MTX cells; IBD; Roseburia intestinalis; commensal bacteria; tight junction proteins; transepithelial electrical resistance (TEER).
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.J Diabetes. 2020 Mar;12(3):224-236. doi: 10.1111/1753-0407.12986. Epub 2019 Oct 30. J Diabetes. 2020. PMID: 31503404 Free PMC article.
-
Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating Treg/Th17 cell balance and intestinal barrier integrity.Biomed Pharmacother. 2023 Nov;167:115568. doi: 10.1016/j.biopha.2023.115568. Epub 2023 Oct 2. Biomed Pharmacother. 2023. PMID: 37793274
-
Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3.Gut Microbes. 2020 Nov 9;12(1):1-16. doi: 10.1080/19490976.2020.1826748. Gut Microbes. 2020. PMID: 33054518 Free PMC article.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation.Nutrients. 2018 Jul 29;10(8):988. doi: 10.3390/nu10080988. Nutrients. 2018. PMID: 30060606 Free PMC article. Review.
Cited by
-
Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease.Hepatol Commun. 2024 Feb 26;8(3):e0310. doi: 10.1097/HC9.0000000000000310. eCollection 2024 Mar 1. Hepatol Commun. 2024. PMID: 38407327 Free PMC article. Review.
-
Long-Term Changes to the Microbiome, Blood Lipid Profiles and IL-6 in Female and Male Swedish Patients in Response to Bariatric Roux-en-Y Gastric Bypass.Nutrients. 2024 Feb 9;16(4):498. doi: 10.3390/nu16040498. Nutrients. 2024. PMID: 38398821 Free PMC article.
-
Influences of Yogurt with Functional Ingredients from Various Sources That Help Treat Leaky Gut on Intestinal Barrier Dysfunction in Caco-2 Cells.Pharmaceuticals (Basel). 2023 Oct 24;16(11):1511. doi: 10.3390/ph16111511. Pharmaceuticals (Basel). 2023. PMID: 38004377 Free PMC article.
-
Recent Advances in Cell-Based In Vitro Models to Recreate Human Intestinal Inflammation.Adv Sci (Weinh). 2023 Nov;10(31):e2301391. doi: 10.1002/advs.202301391. Epub 2023 Sep 21. Adv Sci (Weinh). 2023. PMID: 37736674 Free PMC article. Review.
-
Bioaccessibility and Genoprotective Effect of Melanoidins Obtained from Common and Soft Bread Crusts: Relationship between Melanoidins and Their Bioactivity.Foods. 2023 Aug 24;12(17):3193. doi: 10.3390/foods12173193. Foods. 2023. PMID: 37685126 Free PMC article.
References
-
- Vetrano S., Ploplis V.A., Sala E., Sandoval-Cooper M., Donahue D.L., Correale C., Arena V., Spinelli A., Repici A., Malesci A., et al. Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. Proc. Natl. Acad. Sci. USA. 2011;108:19830–19835. doi: 10.1073/pnas.1107140108. - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
